Table 1.
Anti-microbial drug susceptibility test results for Mycobacterium abscessus subsp. bolletii isolate
| Anti-microbial agent | Minimum inhibitory concentration (MIC) (μg/mL) | Interpretive criteria[[7]] |
|---|---|---|
| Amikacina |
32 |
Intermediate |
| Amoxicillin clavulanateb |
>256 |
Resistant |
| Cefotaximec (disk, 30μg) |
>64 |
Resistant |
| Cefoxitinb |
<8 |
Susceptible |
| Ciprofloxacina |
>16 |
Resistant |
| Clarithromycina |
16 |
Resistant |
| Cotrimoxazolec (disk, 1.25/23.75μg) |
>8 |
Resistant |
| Erythromycinc (disk, 15μg) |
>8 |
Resistant |
| Imipenemb |
0.75 |
Susceptible |
| Levofloxacinc (disk, 5μg) |
>4 |
Resistant |
| Linezolidc (disk, 30μg) |
>8 |
Intermediate/Resistant |
| Minocyclinec (disk, 30μg) |
<4 |
Susceptible |
| Ofloxacinc (disk, 5μg) |
>8 |
Resistant |
| Teicoplaninb |
>256 |
Resistant |
| Tobramycinc (disk, 10μg) |
>8 |
Resistant |
| Tigecyclineb |
>256 |
Resistant |
| Vancomycinb | >256 | Resistant |
aBroth microdilution; bEtest® (AB Biodisk) at 30°C for 72 hours incubation; cdisk diffusion.